These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26809930)

  • 21. Rivaroxaban: liver injury.
    Prescrire Int; 2015 Nov; 24(165):268. PubMed ID: 26688900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Rivaroxaban Therapy on ROTEM Coagulation Parameters in Patients with Venous Thromboembolism.
    Chojnowski K; Górski T; Robak M; Treliński J
    Adv Clin Exp Med; 2015; 24(6):995-1000. PubMed ID: 26771971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivaroxaban-induced liver injury: Results from a venous thromboembolism registry.
    Lambert A; Cordeanu M; Gaertner S; Nouri S; Alt M; Stephan D
    Int J Cardiol; 2015 Jul; 191():265-6. PubMed ID: 25981364
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of rivaroxaban-associated acute tubulointerstitial nephritis.
    Monahan RC; Suttorp MM; Gabreëls BATF
    Neth J Med; 2017 May; 75(4):169-171. PubMed ID: 28522776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.
    Chic Acevedo C; Velasco F; Herrera C
    Future Cardiol; 2015 Sep; 11(5):525-9. PubMed ID: 26090568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolated hemopericardium associated with rivaroxaban: first case report.
    Shivamurthy P; Brar N; Therrien ML
    Pharmacotherapy; 2014 Sep; 34(9):e169-72. PubMed ID: 25074401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation.
    Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A
    A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

  • 29. Medication mismanagement using the rivaroxaban demonstration pack.
    Nguyen TT; MacLasco A; Vitto MJ
    Am J Health Syst Pharm; 2017 Jun; 74(12):872-873. PubMed ID: 28596224
    [No Abstract]   [Full Text] [Related]  

  • 30. [Repeated Cerebellar Hemorrhage Related to Rivaroxaban and Apixaban: A Case Report].
    Yokoi M; Toyama Y; Tsurusaki Y; Nakamura A; Mima Y; Kuwashiro T; Wakugawa Y; Yasaka M; Okada Y
    Brain Nerve; 2016 May; 68(5):573-7. PubMed ID: 27156511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracranial subdural hematomas with elevated rivaroxaban concentration and subsequently detected spinal subdural hematoma: A case report.
    Yamaguchi Y; Koga M; Matsuki T; Hino T; Yokota C; Toyoda K
    Thromb Res; 2016 Jul; 143():127-9. PubMed ID: 27240110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nosebleed in new oral anticoagulant treatment - what should be done?].
    Stiefelhagen P
    MMW Fortschr Med; 2015 Sep; 157(15):25. PubMed ID: 26349711
    [No Abstract]   [Full Text] [Related]  

  • 33. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
    Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
    N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of rivaroxaban using Prothromplex Total, a 4-factor prothrombin complex.
    Kaur H; Yeang SH; See E; Grant D; Tan CW; Wong WH; Tan D; Ng HJ; Lee LH
    Thromb Res; 2017 Aug; 156():117-118. PubMed ID: 28624719
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe dizziness following rivaroxaban introduction in a parkinsonian patient: Drug-drug interaction?
    Lefaucheur R; Le Goff F; Gaillon G; Triquenot-Bagan A; Maltête D
    Presse Med; 2015 Nov; 44(11):1203-4. PubMed ID: 26433836
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous splenic rupture due to rivaroxaban.
    Nagaraja V; Cranney G; Kushwaha V
    Drug Ther Bull; 2018 Nov; 56(11):136-139. PubMed ID: 30355723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tympanic Membrane Haematoma in a RivaroxabanTreated Patient: A Case Report.
    Saldanha I; Matos R; Órfão T; Santos M
    Acta Med Port; 2019 Jun; 32(6):469-470. PubMed ID: 31292030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban-induced hair loss.
    Chrétien B; Besnard A; Sassier M; Le Hello C; Coquerel A; Alexandre J; Fedrizzi S
    Eur J Clin Pharmacol; 2015 Nov; 71(11):1413-4. PubMed ID: 26300206
    [No Abstract]   [Full Text] [Related]  

  • 39. Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation.
    Beyer-Westendorf J; Ehlken B; Evers T
    Europace; 2016 Aug; 18(8):1150-7. PubMed ID: 26830891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivaroxaban-Induced Gastrointestinal Bleeding Presenting as Acute Colon Obstruction.
    Cohen M; Nevo H; Hershko D; Becker A
    Pharmacology; 2017; 99(3-4):124-127. PubMed ID: 27988509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.